EVIO Canada’s Keystone Labs Receives Grant Funding

EVIO Inc. (âEVIOâ or
the âCompanyâ), (EVIO), a leading provider
of cannabis testing and scientific research for the regulated
cannabis industry, is pleased to announce that EVIO Canadaâs
Keystone Labs in Edmonton has received a grant from the
German-Canadian Centre for Innovation and Research (GCCIR). The
overarching goal of the Alberta-Europe Technology Collaboration
Fund is to help participants become more globally competitive by
developing innovative technologies and research-based alliances
with the potential to foster economic growth.

The grant will allow Keystone Labs to partner
with a German company, Mildendo Gesellschaft fur mikrofluidische
Systeme mbH, to complete the development of an innovative real-time
testing platform. By using real-time testing technology throughout
the grow cycle, cultivators can monitor cannabinoid profiles,
potency and other important markers of plant development. The
technology will also aid with monitoring factors which impact plant
health and allow for adjustments throughout the grow cycle.

âWe are excited to collaborate with our global
partners on this game changing testing technology. Technological
advancement in cannabis cultivation will keep Canada at the
forefront of the global industry,â stated Jodi McDonald, President
of EVIO Canadaâs Keystone Labs. âThe two-year commitment of the
GCCIR grant will take the product from development to
commercialization for the global cannabis market.â

EVIO Canada acquired 50% stake in Keystone Labs
in May 2018.

About EVIO Inc.

EVIO Inc. is a leading provider of cannabis
testing and scientific research for the regulated cannabis
industry. The Companyâs EVIO Labs division operates coast-to-coast
providing state-mandated ancillary services to ensure the safety
and quality of the nation's cannabis supply. The Companyâs EVIO
Biosciences Division is dedicated to the scientific, medical, and
psychosocial exploration of clinical cannabis, cannabinoids, and
the endocannabinoid system.

For more information, visit www.eviolabs.com.

About Keystone Labs

Keystone Labs Inc., located in Edmonton, Alberta,
is a privately held Heath Canada accredited testing facility with a
GMP establishment license. Keystone offers a full array of
analytical and microbiological testing services for pharmaceutical,
biotechnology, medical device, nutraceutical, medical cannabis and
related industries.

For more information, visit https://keystonelabs.ca/.

Safe Harbor Statement

Any statements in this press release that are not
statements of historical fact maybe considered to be
forward-looking statements. Statements may contain certain
forward-looking statements pertaining to future anticipated or
projected plans, performance and developments, as well as other
statements relating to future operations and results. Words such as
"may," "will," "expect," "believe," "anticipate," "estimate,"
"intends," "goal," "objective," "seek," "attempt," or variations of
these or similar words, identify forward-looking statements. These
forward-looking statements by their nature are estimates of future
results only and involve substantial risks and uncertainties,
including but not limited to risks associated with the uncertainty
of future financial results, additional financing requirements,
development of new products, our ability to complete our product
testing and launch our product commercially, the acceptance of our
product in the marketplace, the uncertainty of the laws and
regulations relating to cannabis, the impact of competitive
products or pricing, technological changes, the effect of economic
conditions and other uncertainties detailed from time to time in
our reports filed with the Securities and Exchange Commission,
available at www.sec.gov or www.eviolabs.com.

View source version on
businesswire.com:https://www.businesswire.com/news/home/20181213005194/en/

Infuzes.com is the largest cannabis industry database with company profiles, an integrated smart tracker, and global analytics as a resource for cannabis professionals offering essential insights, also giving institutional and retail investors access to real-time, high-quality, reliable market and pricing data.